Teva Pharmaceutical Industries Ltd at Goldman Sachs Global Healthcare Conference Transcript
Good morning, everyone. My name is Nathan Rich, I cover the generic and specialty pharma space for Goldman Sachs. We're very pleased to have Teva here with us this morning. Richard Francis, President and CEO. Thanks very much for being with us and joining us today.
Questions & Answers
Richard, I wanted to start at a high level. I think kind of one of the biggest changes since you launched pivot to growth was really bringing innovative product to the forefront of the messaging for the company, and I think you're starting to get more credit for that. I guess maybe how would you evaluate maybe the progress that you've made on pivot to growth so far in the first year. And I guess, how have you changed how capital and resources internally are deployed as you kind of build buy into this strategy?
Yeah. Well, firstly, thank you for having me. I
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
